Acceptability compliance and adverse reactions when isoniazid, rifampin and pyrazinamide are given as a combined formulation or seperately during three times weekly anti-tuberculosis chemotherapy

Chest Services, Hong Kong and BMRC, London (1989) Acceptability compliance and adverse reactions when isoniazid, rifampin and pyrazinamide are given as a combined formulation or seperately during three times weekly anti-tuberculosis chemotherapy. Ame Rev Resp Dis, 140. 1618.

Full text available as:

HTML
1 Kb

EPrint Type:Article
Uncontrolled Keywords:Clinical Trial; SCC; Isoniazid; Rifampin; Pyrazinamide; Hong Kong Chest Service; BMRC
Subjects:Investigative Techniques > Evaluation Studies > Clinical Trials
Therapeutics > Drug Therapy
Organic Chemicals > Hydrazines > Isoniazid
-Institutional Repositories > National Tuberculosis Institute
Geographic Locations > Asia > Far East > China > Hong Kong
Heterocyclic Compounds > Heterocyclic Compounds with 4 or More Rings > Rifamycins
Respiratory Tract Diseases > Respiratory Tract Infections > Tuberculosis, Pulmonary
Pharmaceutical Preparations > Drug Combinations
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrazines
ID Code:516
Deposited By:Librarian Sudha S Murthy
Deposited On:01 August 2005

Archive Staff Only: edit this record